March 2016

22 Mar

147

Topas Therapeutics Raises EUR 14 Million to Treat Immunological Disorders

In All, Portfolio

Hamburg, Germany, 22 March 2016 – Topas Therapeutics GmbH (“Topas”), a Hamburg/Germany based company, today announced the closing of its Series A financing round. This investment provides the company with EUR 14 million (USD 15.75 million). The round was led by Epidarex Capital and includes…

09 Mar

Edinburgh Molecular Imaging Ltd Awarded Innovate UK Grant to Qualify the Role of EMI-137 in Colorectal Cancer Lesion Detection

In All, Portfolio

Edinburgh, United Kingdom, 9th March, 2016 – Edinburgh Molecular imaging Ltd (EM Imaging) announced today that the company has received a SBRI Stratified Medicine Connecting the UK Infrastructure Phase I grant from the UK’s innovation agency, Innovate UK. The SBRI grant aims to accelerate and increase…